Calendar · pharmadog

Sign In Subscribe

Week of Jan 12, 2026

50

Jan 14, 2026approval228d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

Sponsor: SOMERSET THERAPS LLC. Form: TABLET

full page →ELTROMBOPAG OLAMINE →fda approvals ↗

Jan 14, 2026approval228d agoELTROMBOPAG OLAMINE — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 14, 2026approval228d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Jan 14, 2026approval228d agoTOREMIFENE CITRATE — FDA approvalTOREMIFENE CITRATE

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →TOREMIFENE CITRATE →fda approvals ↗

Jan 14, 2026approval228d agoMYCOPHENOLATE SODIUM — FDA approvalmycophenolate sodium DR

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →mycophenolate sodium DR →fda approvals ↗

Jan 14, 2026approval228d agoROGAINE EXTRA STRENGTH (FOR MEN) (MINOXIDIL) — FDA approvalVeradermics, Inc

Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL

full page →fda approvals ↗

Jan 14, 2026approval228d agoSITAGLIPTIN PHOSPHATE — FDA approvalSITAGLIPTIN PHOSPHATE

Sponsor: SANDOZ. Form: TABLET. Route: ORAL

full page →SITAGLIPTIN PHOSPHATE →fda approvals ↗

Jan 14, 2026approval228d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Jan 14, 2026approval228d agoMETHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approvalPFIZER INC

Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Jan 14, 2026approval228d agoMETHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approvalPFIZER INC

Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Jan 14, 2026approval228d agoANAGRELIDE HYDROCHLORIDE — FDA approvalANAGRELIDE HYDROCHLORIDE

Sponsor: RISING. Form: CAPSULE. Route: ORAL

full page →ANAGRELIDE HYDROCHLORIDE →fda approvals ↗

Jan 14, 2026grant228d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Role of host glutaminolysis in tuberculosis pathogenesis

GM grant. $196,875. PI: Stephania A Cormier

full page →nih reporter ↗

Jan 15, 2026approval227d agoOSELTAMIVIR PHOSPHATE — FDA approvalOSELTAMIVIR PHOSPHATE

Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

full page →OSELTAMIVIR PHOSPHATE →fda approvals ↗

Jan 15, 2026approval227d agoREZUROCK (BELUMOSUDIL MESYLATE) — FDA approvalbelumosudil mesylate

Sponsor: KADMON PHARMS LLC. Form: TABLET. Route: ORAL

full page →belumosudil mesylate →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoOTULFI (USTEKINUMAB-AAUZ) — FDA approvalOTULFI

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

full page →OTULFI →fda approvals ↗

Jan 15, 2026approval227d agoNAPROXEN SODIUM — FDA approvalNAPROXEN SODIUM

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →NAPROXEN SODIUM →fda approvals ↗

Jan 15, 2026approval227d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗

Jan 15, 2026approval227d agoFILKRI (FILGRASTIM-LAHA) — FDA approvalfilgrastim biosimilar

Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: INJECTION

full page →filgrastim biosimilar →fda approvals ↗

Jan 15, 2026approval227d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗

Jan 15, 2026approval227d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMacleods Pharmaceuticals Ltd

Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026approval227d agoTEPADINA AND SODIUM CHLORIDE (THIOTEPA) — FDA approvalRevalesio Corp

Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 15, 2026approval227d agoOXALIPLATIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: SHANDONG. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 15, 2026approval227d agoALVAIZ (ELTROMBOPAG CHOLINE) — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 15, 2026grant227d agoUNIVERSITY OF WISCONSIN MILWAUKEE — Effects of older age on the neural basis of memory generalization

AG grant. $293,454. PI: Caitlin R. Bowman

full page →nih reporter ↗

Jan 15, 2026grant227d agoMIRIAM HOSPITAL — Applying a just-in-time adaptive intervention framework to understand and tre...

GM grant. $223,500. PI: KayLoni L. Olson

full page →nih reporter ↗

Jan 15, 2026grant227d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Preclinical development of breakthrough immunotherapy for brain tumorsUniversity of California San Francisco

NS grant. $943,253. PI: Hideho Okada

full page →nih reporter ↗

Jan 15, 2026grant227d agoUNIVERSITY OF IOWA — Determining the Impact of Metabolic Syndrome on the Oral Microbiome and Perio...University of Iowa

DE grant. $699,184. PI: Sukirth Murthy Ganesan

full page →nih reporter ↗

Jan 15, 2026grant227d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — (Micro)structural Biomarkers of Skeletal Muscle Health Across the LifespanNew York University

AG grant. $466,125. PI: Valentina Mazzoli

full page →nih reporter ↗

Jan 15, 2026grant227d agoWEST VIRGINIA UNIVERSITY — Nanoscale synaptic heterogeneity, loss, and plasticity in Alzheimer's diseaseMetallomix Inc

AG grant. $476,159. PI: Martin Hruska

full page →nih reporter ↗

Jan 15, 2026grant227d agoUNIVERSITY OF CALIFORNIA BERKELEY — Photoactivation of Supramolecular Hosts: Novel Chemical Reactivity Through Ph...

GM grant. $1. PI: Katherine Carmen Forbes

full page →nih reporter ↗

Jan 15, 2026grant227d agoUNIVERSITY OF DELAWARE — Novel in situ analysis of the functional impacts of osteoarthritis in the mou...

AG grant. $560,380. PI: Stephanie Grace Cone

full page →nih reporter ↗

Jan 15, 2026grant227d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Mitochondrial and energetic underpinnings of resilience in human aging: integ...

AG grant. $690,865. PI: Alan A. Cohen

full page →nih reporter ↗

Jan 15, 2026grant227d agoNORTH CAROLINA STATE UNIVERSITY RALEIGH — BOWiD: a tool for lifelong tracking C. elegans individuals using stochastical...

AG grant. $580,636. PI: Adriana San Miguel

full page →nih reporter ↗

Jan 15, 2026grant227d agoUNIVERSITY OF PENNSYLVANIA — Investigating the Role of Genetic Variants and Aging on Eicosanoid Metabolism...University of Pennsylvania

AG grant. $446,875. PI: Eleonora Scorletti

full page →nih reporter ↗

Jan 15, 2026grant227d agoUT SOUTHWESTERN MEDICAL CENTER — Identification of metabolic regulators of hepatic phosphatidylcholine synthesis

DK grant. $676,279. PI: Javier Garcia Bermudez

full page →nih reporter ↗

Jan 15, 2026grant227d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — GABAergic Circuit Targets for Modulating Entorhinal Cortex and Hippocampal Dy...New York University

AG grant. $642,063. PI: Jayeeta Basu

full page →nih reporter ↗

Jan 15, 2026grant227d agoWASHINGTON UNIVERSITY — Transgenerational Adaptation of Longevity Changes in Response to Repeated Env...

AG grant. $556,121. PI: Eric Lieberman Greer

full page →nih reporter ↗

Jan 15, 2026grant227d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — AMPA Receptor Function at Interneuron Synapses

NS grant. $186,250. PI: Jacques Wadiche

full page →nih reporter ↗

Jan 15, 2026grant227d agoSTANFORD UNIVERSITY — The brain as a control center for other organs during agingStanford University

AG grant. $1,468,868. PI: ANNE BRUNET

full page →nih reporter ↗

Jan 16, 2026approval226d agoZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalloncastuximab tesirine

Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION

full page →loncastuximab tesirine →fda approvals ↗

Jan 16, 2026approval226d agoBRIUMVI (UBLITUXIMAB-XIIY) — FDA approvalublituximab

Sponsor: TG THERAPEUTICS, INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →ublituximab →fda approvals ↗

Jan 16, 2026approval226d agoLEQEMBI (LECANEMAB-IRMB) — FDA approvallecanemab

Sponsor: EISAI INC. Form: INJECTABLE. Route: INJECTION

full page →lecanemab →fda approvals ↗

page 412 of 475